ArticlePharmaceutics2023

A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells.

Yingying Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.